(Q37122496)

18 August 2017

1 reference

title

The appropriate use of B-cell function testing in the preclinical period of type 1 diabetes (English)

1 reference

18 August 2017

The Appropriate Use of B-cell Function Testing in the Preclinical Period of Type 1 Diabetes (English)

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

6 December 2022

0 references

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

6 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

6 December 2022

2

J. P. Palmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837505

6 December 2022

author name string

D. K. McCulloch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837505

6 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1837505

6 December 2022

publication date

1 November 1991

1 reference

full work available at URL

18 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.1991.tb02116.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.1991.tb02116.x/fullpdf

6 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

6 December 2022

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

9

1 reference

18 August 2017

page(s)

800-804

1 reference

Evidence of beta cell dysfunction which does not lead on to diabetes: a study of identical twins of insulin dependent diabetics

18 August 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients.

6 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Beta-cell function and insulin sensitivity in nondiabetic HLA-identical siblings of insulin-dependent diabetics.

6 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Diagnosis of pre-type I diabetes

6 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetes

6 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study

6 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children

6 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Insulin, Glucagon, and Glucose Exhibit Synchronous, Sustained Oscillations in Fasting Monkeys

6 December 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration

6 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Decreased insulin- and glucagon-pulse amplitude accompanying beta-cell deficiency induced by streptozocin in baboons.

6 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Potentiation of Insulin Secretory Responses by Plasma Glucose Levels in Man: Evidence That Hyperglycemia in Diabetes Compensates for Impaired Glucose Potentiation*

6 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man.

6 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

6 December 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Defects in beta-cell function and insulin sensitivity in normoglycemic streptozocin-treated baboons: a model of preclinical insulin-dependent diabetes.

6 December 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Differential Sensitivity to β-Cell Secretagogues in “Early,” Type I Diabetes Mellitus

6 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Quantitative estimation of insulin sensitivity

6 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values.

6 December 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

The Insulin Sensitivity Index: Correlation in Dogs Between Values Determined from the Intravenous Glucose Tolerance Test and the Euglycemic Glucose Clamp

6 December 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values.

6 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

6 December 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study

6 December 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

The modified minimal model: application to measurement of insulin sensitivity in children.

6 December 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboons.

6 December 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

6 December 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans

6 December 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

Between and within subject variation of the first phase insulin response to intravenous glucose.

6 December 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB02116.X

6 December 2022

Identifiers

1 reference

18 August 2017

1 reference